Zeocin Selection Antibiotic is a formulation of phleomycin D1, a glycopeptide antibiotic produced by Streptomyces verticillus.

Gibco Zeocin Selection Antibiotic is a formulation of phleomycin D1, a glycopeptide antibiotic produced by Streptomyces verticillus. It acts by binding to and cleaving DNA, leading to cell death, and is used for selection of of mammalian, insect, yeast, bacterial, and plant cell cultures. Working concentration range is 50–400 μg/mL depending on the cell type. This product is supplied at 100 mg/mL in sterile water in 8 x 1.25 mL vials.

• Gibco™ Zeocin™ Selection Antibiotic is a formulation of phleomycin D1, a glycopeptide antibiotic produced by Streptomyces verticillus

• Zeocin™ Selection Antibiotic acts by binding to and cleaving DNA, leading to cell death

• It is used for selection of of mammalian, insect, yeast, bacterial, and plant cell cultures

• Working concentration ranges between 50–400 μg/mL depending on the cell type

• This product is supplied at 100 mg/mL in sterile water, in 8 x 1.25 mL vials